BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 26626189)

  • 1. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
    Denzer I; Münch G; Friedland K
    Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
    Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
    Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
    Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
    Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J
    Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.
    Esteras N; Dinkova-Kostova AT; Abramov AY
    Biol Chem; 2016 May; 397(5):383-400. PubMed ID: 26812787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
    Johnson DA; Johnson JA
    Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
    Buendia I; Michalska P; Navarro E; Gameiro I; Egea J; León R
    Pharmacol Ther; 2016 Jan; 157():84-104. PubMed ID: 26617217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
    George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
    Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration.
    Goodfellow MJ; Borcar A; Proctor JL; Greco T; Rosenthal RE; Fiskum G
    Exp Neurol; 2020 Jun; 328():113247. PubMed ID: 32061629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
    Cheng X; Ku CH; Siow RC
    Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin reduces oxidative stress and improves mitochondrial dysfunction via activation of the Nrf2/ARE signaling pathway in neurons.
    Wang K; Chen Z; Huang L; Meng B; Zhou X; Wen X; Ren D
    Int J Mol Med; 2017 Nov; 40(5):1582-1590. PubMed ID: 28949376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
    Sivandzade F; Prasad S; Bhalerao A; Cucullo L
    Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
    Islam MT
    Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.
    Johnson JA; Johnson DA; Kraft AD; Calkins MJ; Jakel RJ; Vargas MR; Chen PC
    Ann N Y Acad Sci; 2008 Dec; 1147():61-9. PubMed ID: 19076431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
    Kanno T; Tanaka K; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Hirayama N; Ikeda JE
    Free Radic Biol Med; 2012 Dec; 53(11):2028-42. PubMed ID: 23000247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
    Xiang Y; Song X; Long D
    Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
    Lee DH; Gold R; Linker RA
    Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
    Zgorzynska E; Dziedzic B; Walczewska A
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.